Paragraph IV Patent Protection and Litigation CLE

To learn more about this webcast please visit our website:

Join us for this Knowledge Group Online CLE Paragraph IV Webinar. Protecting pharmaceutical patents in today’s business landscape is even made more challenging by the growing number of threats and risks. One of the crucial weak spots for drug companies aiming to guard their patents is the Abbreviated New Drug Application (ANDA) process, particularly Paragraph IV (PIV) certification. It is already becoming common for brand companies to receive a PIV challenge from a generic company.

The increasing PIV filings require both patent holders and challengers to be equipped with up-to-date knowledge of addressing complex challenges surrounding patent protection and PIV disputes.

In this Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide insights on how to manage the complex challenges that both brand name and generic drug manufacturers face. The speakers will present the recent patent infringement cases that have significant implications on the current legal setting. They will also offer the best practices in protecting patents and litigating PIV effectively.